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Abstract: Despite very intensive research in the synthesising of new cytostatics, cisplatin is 
still one of the most commonly used anticancer drugs. Therefore, an investigation of 
interactions of cisplatin with different biologically important amino acids, peptides and 
proteins is very topical. In the present paper, we utilized flow injection analysis coupled 
with electrochemical detection to study and characterize the behaviour of various forms of 
glutathione (reduced glutathione – GSH, oxidized glutathione – GSSG and S-nitroso 
glutathione – GSNO). The optimized conditions were as follows: mobile phase consisted 
of acetate buffer (pH 3) with a flow rate of 1 mL min-1. Based on results obtained we chose 
850 mV as the optimal potential for detection of GSH and 1,100 mV as the optimal 
potential for detection of GSSG and GSNO. The detection limits of GSH, GSSG and 
GSNO were 100 pg mL-1, 50 ng mL-1 and 300 pg mL-1, respectively. Further, the optimized 
Sensors 2007, 7                            
 
 
1257
technique was used for investigation of interactions between cisplatin and GSH. We were 
able to observe the interaction between GSH and cisplatin via decrease in the signal 
corresponding to glutathione. Moreover, we evaluated the formation of the complex by 
spectrometry. The spectrometric results obtained were in good agreement with 
electrochemical ones. 
Keywords: Glutathione; Carbon paste electrode; Thiols; Cisplatin; Cancer; Flow injection 
analysis with electrochemical detection. 
 
1. Introduction 
Glutathione was discovered by M. J. de Rey Pailhade at the end of the 19th century as the substance 
“hydrogénant le soufre”, which was renamed by F.G. Hopkins in 1921. Hopkins first characterised the 
compound as a dipeptide of glutamic acid and cysteine. Few years later he suggested the correct 
structure to be a tripeptide which also contains glycine [1]. GSH as a ubiquitous tripeptide thiol is a 
vital intra- and extra-cellular protective antioxidant. It plays a number of key roles in the controlling of 
signalling processes, detoxifying of some xenobiotics and heavy metals etc. Glutathione is found 
almost exclusively in its reduced form; since the enzyme, which reverts it from its oxidized form 
(GSSG) called glutathione reductase, is constitutively active and inducible upon oxidative stress. In 
fact, the ratio of reduced to oxidized glutathione within cells is often used as a marker of cytotoxicity 
[2-5]. In connection with this, many fundamental events of cell regulation such as protein 
phosphorylation and binding of transcription factors to consensus sites on DNA are driven by 
physiological oxidant-antioxidant homeostasis, especially by thiol-disulfide balance. Therefore 
endogenous glutathione and thioredoxin systems and may be considered to be effective regulators of 
redox-sensitive gene expression [6-9]. 
The sulfhydryl group of glutathione is highly reactive and is often found conjugated to other 
molecules such as nitric oxide (NO) [10-14]. Nitrosation of the glutathione may serve as a signal event 
and/or as a deposition of NO to S-nitrosoglutathione. Thus, GSH can serve also as a substrate in 
conjugation reactions [15]. 
Based on the facts mentioned above it is not surprising that GSH can influence the treatment of 
diseases, such as cancer [16-18]. In malignant tumours, as compared with normal tissues, the multidrug 
resistance associates mostly with higher GSH levels within these cancer cells [19]. Thus, approaches to 
cancer treatment based on modulation of GSH should control possible tumour growth-associated 
changes in GSH content and synthesis in these cells [20-23]. An investigation of the interaction of 
GSH with heavy metal based cytostatics can be one of the possible ways of studying of reasons how 
GSH can interrupt the cancer treatment [24]. The heavy metal based cytostatics, most of all platinum 
complexes, play an important role in the chemotherapy of various malignancies [25-31]. The biological 
activity of the first platinum based cytostatic drug – cisplatin (cis-diamminedichloroplatinum(II)), 
which is still one of the most frequently used cytotoxic agents, was discovered in 1965 by Rosenborg 
during his studies on the effects of an electric current on bacterial growth [32]. Since then hundreds of 
platinum(II) and platinum(IV) complexes have been synthesized and evaluated as anticancer agents 
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over the past 40 years. Despite very intensive research in the synthesising of new cytostatics, cisplatin 
is still one of the most commonly used anticancer drugs. Therefore, an investigation of interactions of 
cisplatin with different biologically important amino acids, peptides and proteins is very topical. Many 
experimental or soft modelling methods have been proposed for these purposes,[33-39]. In the present 
paper, we attempted to utilize flow injection analysis coupled with electrochemical detection to study 
and characterize behaviour of various glutathiones (reduced – GSH, oxidized – GSSG and S-nitroso – 
GSNO, Fig. 1). Frther, the optimized technique was used for investigation of interactions between 
cisplatin and reduced GSH. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Chemical structures of reduced (GSH), oxidized (GSSG) and S-nitroso (GSNO) 
glutathiones. Square wave voltammograms of GSH, GSSG and GSNO measured on carbon paste 
electrode using AUTOLAB Analyser. The supporting electrolyte: Britton-Robinson buffer, pH 5. SWV 
parameters were as follows: the initial potential of –0.2 V, the end potential 1.5 V, frequency 200 Hz 
and step potential 5 mV. The concentration of thiols was 100 µM. 
2. Experimental 
2.1 Chemicals 
Reduced glutathione (GSH), oxidised glutathione (GSSG), S-nitrosoglutathione (GSNO) sodium 
tetraborate and other chemicals used were purchased from Sigma Aldrich (St. Louis, USA) unless 
noted otherwise. Tris(2-carboxyethyl)phosphine (TCEP) is produced by Molecular Probes (Evgen, 
Oregon, USA). Stock standard solutions of GSH, GSSG and GSNO (100 mg mL-1) were prepared with 
ACS water (Sigma-Aldrich, USA) and stored in the dark at –20 °C. In addition GSH solutions were 
prepared in the presence of reduction agent TCEP to avoid oxidation [40]. Working standard solutions 
were prepared daily by dilution of the stock solutions. The pH value was measured using WTW inoLab 
50 nA
Potential = 0.548 V
GSH GSNO
Potential = 1.163 V
GSSG
Potential (V)
0.3 0.5 0.7
Potential (V)
0.9 1.1 1.3
Potential (V)
0.9 1.1 1.3
Potential = 1.180 V
10 nA 10 nA
HN HN
O HS
O
O
HO
NH2
O
OH
NH
NH O
S
O
S
O
HO
NH2HN
O
OHHN
O
OO
HO
H2N
O
OH
HN HN
O S
O
O
HO
NH2
O
OH
N
O
Sensors 2007, 7                            
 
 
1259
(Weilheim, Germany). The pH-electrode (SenTix-H, pH 0–14/3M KCl) was regularly calibrated with 
WTW buffers (Weilheim, Germany).  
 
2.2 Preparation of cisplatin solutions  
The chemotherapeutic drug of cisplatin was synthesized and provided by Pliva-Lachema (Brno, 
Czech Republic) [41]. Stock standard solutions of cisplatin (500 µg mL-1) were prepared by sodium 
chloride solution (0.5 M, pH 6.4) and stored in the dark at -20 °C [38,42]. Working standard solutions 
were prepared daily by dilution of the stock solutions in phosphate buffer (100 mM). 
 
2.3 Electrochemical measurements 
Electrochemical measurements were performed with AUTOLAB Analyser (EcoChemie, 
Netherlands) connected to a VA-Stand 663 (Metrohm, Switzerland), using a standard cell with three 
electrodes. The working electrode was a carbon paste electrode (CPE). The reference electrode was the 
Ag/AgCl/3M KCl electrode and the auxiliary electrode was the graphite electrode. All experiments 
were carried out at room temperature. The carbon paste was made of 70 % graphite powder (Sigma 
Aldrich) and 30 % mineral oil (Sigma Aldrich). The carbon paste was housed in a Teflon body having 
a 2.5 mm diameter of active disk surface. The electrode surface was polished before each 
determination with a soft filter paper prior to measurement [43-45]. For smoothing and baseline 
correction [46], the software GPES 4.4 was employed. 
 
2.4 Square wave voltammetry measurements of GSH, GSSG and GSNO 
The GSH, GSSG and GSNO were measured using SWV at the surface CPE. The supporting 
electrolyte (Britton-Robinson buffer, pH 5) was purchased from Sigma Aldrich in ACS purity.  SWV 
parameters were as follows: the initial potential of –0.2 V, the end potential 1.5 V, frequency 200 Hz 
and step potential 5 mV. For other experimental details see references [40,47]. 
 
2.5 Preparation of GS-Pt complexes 
The GS-Pt complex was prepared according to Ishikawa and Ali-Osman [48] by incubation of GSH 
(60 µg mL-1) with cisplatin (30 µg mL-1) in 500 µl of 100 mM phosphate buffer pH 7.8 in the dark at 
37 °C (thermostat BTV Brno) [49]. 
 
2.6 Flow electrochemical measurement 
An FIA-ED system consisted of a solvent delivery pump operating in the range of 0.001-9.999 
ml/min (Model 582 ESA Inc., Chelmsford, MA, USA), a guard cell (Model 5020 ESA, USA), a 
reaction coil (1 m) and an electrochemical detector. The amperometric electrochemical detector (ED) 
includes one low volume flow-through analytical cell (Model 5040, ESA, USA), which consists of a 
glassy carbon working electrode, a palladium electrode as a reference electrode and an auxiliary carbon 
electrode, and a Coulochem III as a control module. The sample (5 µl) was injected manually. The 
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obtained data were treated by CSW 32 software. The experiments were carried out at room temperature 
(22 °C). A glassy carbon electrode was polished mechanically by 0.1 µm of alumina (ESA Inc., USA) 
and sonicated at room temperature for 5 min using a Sonorex Digital 10 P Sonicator (Bandelin, Berlin, 
Germany) at 40 W. 
 
2.7 Spectroscopic analysis 
Spectra of GSH, cisplatin and their complexes were recorded in the presence pf 100 mM phosphate 
buffer (pH 7.8) using a Helios spectrophotometer (Analytic Jena, Germany). 
 
2.8 Statistical analysis 
STATGRAPHICS® (Statistical Graphics Corp®, USA) was used for statistical analyses. Results 
are expressed as mean ± S.D. unless otherwise noted. Values of p < 0.05 were considered significant. 
3. Results and Discussion 
3.1 Stationary electrochemical system 
Firstly we focused on studying the basic electrochemical properties of target molecules. Reduced 
(GSH), oxidised (GSSG) and S-nitroso (GSNO) glutathione were measured by square wave 
voltammetry using carbon paste electrode. We investigated how the compounds of interest behave in 
the presence of Britton-Robinson buffer (pH 5) as a supporting electrolyte. We found that certain 
glutathiones can be determined on CPE in concentrations below 1 µM. Reduced glutathione gave 
oxidation signals near 0.56 V, oxidized glutathione approximately 1.16 V and nitrosoglutathione at 
about 1.19 V. The shift of potentials of the target molecules to more positive values can be probably 
related with the higher energy necessary to oxidize stronger bonds as S-S and S-NO compared to free–
SH group (Fig. 1). 
 
3.2 Electrochemical analysis of glutathiones in flow system 
When we assessed that the glutathiones can be measured at solid electrodes (Fig. 1), flow injection 
analysis using glassy carbon electrode as a working one was utilized for measurement of the 
compounds of the interest. The flow rate of the mobile phase (Britton-Robinson, pH 5.0) was the first 
experimental condition we optimized. The influence of flow rate on the electrochemical responses of 
the target molecules was investigated within the range from 0.4 to 1.5 mL min-1 at a working potential 
of 700 mV. The responses enhanced with increasing flow rate to 1.0  mL min-1 and then slightly 
decrease. Based on the obtained results we chose 1.0 mL min-1 as the optimal flow rate of the mobile 
phase. The observed signals were well developed and symmetrical (not shown). 
3.2.1 Mobile phase composition and its pH 
 Other experimental conditions such as composition of mobile phase and its pH were also 
optimized. We choose three various buffers (acetate, phosphate and Britton-Robinson) and investiagted 
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how their different pH values can affect the electrochemical responses of glutathiones (Fig. 2). It 
clearly follows from the results obtained that acetate buffer (pH 3) was the most suitable mobile phase 
to measure glutathiones with the highest sensitivity. If phosphate buffer was used, the lowest signals 
were measured. Particularly, the peak heights of glutathiones measured in the presence of phosphate 
buffer were about 80 % lower than in acetate buffer. Similarly, if we used Britton Robinson buffer as 
the mobile phase signals were about 20-60 % lower than in acetate buffer. It clearly follows from the 
obtained results that the electrochemical responses of glutathiones measured on a glassy carbon 
electrode are affected not only by the composition of the mobile phase but also by its pH (Fig. 2). 
Moreover it can be concluded that the higher pH values used, the lower the electrochemical responses 
of compounds of interest were observed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Influence of pH of acetate, phosphate and Britton-Robinson buffers on electrochemical 
responses of GSH, GSSG and GSNO. Concentration of the buffers: 0.2 M. Flow rate of electrolyte was 
1.0 ml.min-1, potential 700 mV. Signal of GSH measured in the presence of acetate buffer (pH 3.0) of 
height 468 µA corresponds to 100 %. The concentration of thiols was 30 µg mL-1. 
3.2.2 Applied potential on glassy carbon working electrode 
As we have optimized flow rate of a mobile phase and its composition, a working electrode 
potential was the last experimental conditions we optimized. We measured glutathiones of the same 
concentration (30 µg mL-1) in the presence of acetate buffer (pH 3) with a flow rate of 1 mL min-1 at 
various working electrode potentials. The hydrodynamic voltammograms obtained are shown in Fig. 3. 
If GSH was measured, the rapid increase of the signal with maximum at 900 mV was observed. The 
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increase of the electrochemical responses of GSSG and GSNO were observed at potentials higher than 
800 mV. The peaks increased to 1,300 mV, where the highest peaks of GSSG and GSNO were 
observed. If we compared the potentials of the highest peaks of glutathiones measured by flow 
technique to those measured by SWV, we found that the potentials measured by flow technique shifted 
slightly to more positive values (Fig. 1 and Fig. 3). The shift can be associated with different reference 
and working electrodes used (hydrogen-palladium in flow system and Ag/AgCl, 3M KCl in stationary). 
Based on the results obtained we choose 850 mV as the optimal potential for detection of GSH and 
1,100 mV as the optimal potential for detection of GSSG and GSNO. The signals of GSSG and GSNO 
measured under potentials higher than 1,100 mV were higher but the stabilizing of background currents 
lasted more than twenty minutes and standard deviations exceeded 10 %. These disadvantages 
encouraged us to utilize 1,100 mV for detection of GSSG and GSNO in the following experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Hydrodynamic voltammograms of GSH, GSSG and GSNO measured on glassy carbon 
electrode. Mobile phase: 0.2 M acetate buffer. For other details see Fig. 2. 
3.2.3 Calibration curves 
Under the experimental conditions optimized above we investigated the influence of glutathiones 
concentration on their current responses. The dependences measured are shown in Figs. 4A,B,C. The 
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dependences were nonlinear within the concentration ranges we studied, whereas the linear ranges of 
the dependences are shown in insets in Figs. 4A,B,C. The nonlinearity observed can be associated with 
an accumulation of analyte on the electrode surface, where poly-layers of analyte adsorbed could form 
[50]. In addition, the signals were very well reproducible with a relative standard deviation of 2-5%. 
GSSG gave the lowest current responses in comparison with other compounds of interest. The 
concentration dependence of GSSG was linear (y = 5.4816x + 0.4914; R2 = 0.9939) within the 
concentration range from 0.1 to 2.5 µg mL-1, with a detection limit of 50 ng mL-1. If we measured 
GSNO, we obtained strictly linear concentration dependence (y = 0.0052x + 0.2099; R2 = 0.9957) 
within the range from 1 to 500 ng mL-1, whereas the detection limit was 300 pg mL-1. In addition, GSH 
concentration dependence was strictly linear (y = 11.315x - 0.5146; R2 = 0.9969) within the range from 
0.5 to 4 ng mL-1. The detection limit of GSH was 100 pg mL-1 (Fig. 4). The detection limits were 
evaluated as 3 S/N ratio according to Long and Winefordner [51]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Dependences of peak heights of GSH (A), GSSG (B) and GSNO (C) on their concentrations; 
insets: calibration dependences of the thiols and real chromatograms. For other details see Fig. 3. 
3.3 Study of GSH-cisplatin interaction 
GSH belongs to group of thiols, like metalothioneins, which could most likely influence therapeutic 
concentration of platinum based cytostatics (e.g. cisplatin) within a body and, therefore, could play one 
of the key roles in formation of a resistance on the treatment [52-57]. A mechanism of action of GSH 
with cisplatin is still unclear, but the most accepted opinion is that the thiol decreases of therapeutic 
concentration in the place of the drug action [58-60]. The contribution of other forms of glutathiones 
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including GSNO and/or GSSG to decrease of therapeutic concentration of platinum based cytostatics is 
thought to be negligible due to their few folds lower concentration and reactivity. Thus, studying of 
interactions between these low abundant glutathiones with cytostatics is of low clinical importance. 
Nevertheless, investigating of interactions between GSH and cytostatics if of high importance but it is 
very difficult and needs robust and high cost instruments as nuclear magnetic resonance. 
Here, we propose a simple method to characterize the interactions of GSH with cisplatin. 
Therapeutic doses of cisplatin (3, 15 and 30 µg mL-1) were used for this purpose. GS-Pt complexes 
were prepared according to Ishikawa and Ali-Osman [48]. We observed the interaction between 
ciplatin and GSH by determining of changes in GSH signal. As expected, the formed GS-Pt complex 
gave lower responses compared to reduced glutathione (Fig. 5A). Therefore, the hydrodynamic 
voltammograms of GSH and GS-Pt complex measured in the range from 400 to 1,100 mV differed. 
The current response of GS-Pt complex increased slowly up to an applied potential of 750 mV, then 
the rapid increase of the signal with maximum at 900-950 mV occurred (Fig. 5A). Therefore we further 
measured the GS-Pt complex at 950 mV. Moreover, the signal of cisplatin (30 µg mL-1) under these 
experimental conditions was negligible. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Hydrodynamic voltammograms of GSH and GS-Pt complex (1 µg mL-1) after 60 h long 
interactions (A). Dependences of height of GSH and GS-Pt complex on time and time of interaction, 
respectively (B). Signal of GSH of height 46.7 µA (A) and of height 1,620 µA (B) corresponds to 100 
%. Cisplatin (30 µg mL-1) and GSH (60 µg mL-1) interacted in the presence of phosphate buffer (pH 
7.8) in the dark at 37 °C. For other details see Fig. 4. 
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During time scale investigating of formation complexes between GSH and cisplatin we also studied 
if the height of GSH peaks without cisplatin can change. We found the peak of GSH decreased 
gradually within the range of time we were interested in (Fig. 5B). In addition, the dependence of peak 
height of GS-Pt complex on times of interactions is shown in Fig. 5B. It clearly follows from the 
results obtained that dependences differed markedly, which confirmed that we really observed the 
interactions between cisplatin and GSH. The signal of complex decreased more than 40 % during the 
20 h long interaction at 37 °C. Moreover, after a 60 h long interaction the maximum yield of complex 
had been reached. We also decided to evaluate the formation of complex by another reference 
technique. The complex formation was monitored spectrometrically as absorbance change at 280 nm 
[49]. The spectrometric results obtained were in good agreement with electrochemical ones. 
Conclusion 
Electrochemical detection represents an alternative method for determination of biologically active 
compounds [42,61-71]. Here, we have shown the flow injection analysis coupled with electrochemical 
detector could be a suitable technique not only for direct detection of various forms of glutathione but 
also for investigating of interactions between thiols and cytostatics. FIA-ED is very promising tool for 
such purposes because it is low cost and very sensitive to various electroactive species. 
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